Why did the Thermo Fisher-Qiagen deal fall apart?

Themo Fisher’s portfolio of over 200 Covid-19 vaccine and therapeutic candidates may turn out to be more future-proof than Qiagen’s offering. Credit: Wikimedia Commons



  • thermo fisher qiagen deal